Respiratory

asthma inhaler

GINA asthma strategy: what’s new for 2021?

2021-06-22T15:52:00+01:00By Dr Mark L Levy

Dr Mark L Levy highlights updated recommendations on asthma management from the 2021 Global Initiative for Asthma report

lungs_visualisation_web

Key learning points: managing bronchiectasis in adults

2021-04-29T11:24:00+01:00By Dr Kevin Gruffydd-Jones

Dr Kevin Gruffydd-Jones identifies six key learning points for primary care from the British Thoracic Society guideline on bronchiectasis

vaccine

Understanding and overcoming COVID-19 vaccine hesitancy

2021-04-29T10:13:00+01:00By Dr Claire Davies

Dr Claire Davies explores reasons underlying, and methods of addressing, reluctance to receive COVID-19 vaccination

Brochi Visualisation

GOLD COPD strategy: what’s new for 2021?

2021-02-24T13:16:00+00:00By

Professor David Halpin describes the key updates in the 2021 GOLD COPD report and highlights new recommendations about patients with COPD and COVID-19

Inhaler with spacer device

Interim guidance aims to reduce confusion around asthma management

2020-11-21T12:35:00+00:00By Dr Sinan Eccles

Dr Sinan Eccles discusses how the interim All Wales guideline offers pragmatic advice to primary care to help address conflicts in current guidance for asthma

Educational resources

asthma inhaler

The importance of inhaler choice

Commissioned by Boehringer Ingelheim Limited

Information intended for UK healthcare professionals only. This promotional webinar was commissioned and funded by Boehringer Ingelheim and developed in partnership with Guidelines in Practice
View prescribing information here.
PC-GB-104812
Date of preparation: June 2021

Soprobec FDG image update_index image

Soprobec (beclometasone dipropionate) pMDI

Commissioned by Glenmark Pharmaceuticals Europe Ltd

This formulary decision guide was developed from content provided by Glenmark Pharmaceuticals Europe Ltd in a format developed by Guidelines in Practice.
View prescribing information
PP-UK-SOP-0130 V2 March 2021

Animation index image

Respimat® Soft Mist reusable inhaler: patient benefits and environmental impact

Commissioned by Boehringer Ingelheim Limited

This promotional animation has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines in Practice
View prescribing information
PC-GB-103871 February 2021

GiP Index Image

The re-usable Respimat® Soft Mist inhaler

Commissioned by Boehringer Ingelheim Limited

This promotional supplement has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines in Practice
View prescribing information
PC-GB-103142 November 2020

Index image_Soprobec supplement_PI update

Practical tips for maintaining asthma care prompted by a supply issue during the COVID-19 pandemic

Commissioned by Glenmark Pharmaceuticals Europe Ltd

This supplement has been commissioned and funded by Glenmark Pharmaceuticals Europe Ltd and developed in partnership with Guidelines in Practice.
View prescribing information
PP-UK-SOP-0129 December 2020